About
Technology
Issues
FAQ
Links
Official Page
Changes in Cardiovascular Biomarkers Associated With the Sodium–Glucose Cotransporter 2 (SGLT2) Inhibitor Ertugliflozin in Patients With Chronic Kidney Disease and Type 2 Diabetes
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.